Stay updated on Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page.

Latest updates to the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changes from v3.7.0 to v3.7.1; the 403 error page otherwise remains unchanged.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now loads a 403 Forbidden error page, replacing the usual study content with a standard error screen. This blocks access to the study record while retaining the site chrome (header/footer).SummaryDifference19%

- Check51 days agoChange DetectedThe page footer now displays Revision: v3.6.6, indicating a minor maintenance update rather than a change to study information.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page's version label was updated from Revision: v3.6.4 to v3.6.5, indicating a new deployment. This update is a metadata change reflecting deployment activity rather than a change to the study information.SummaryDifference0.1%

- Check86 days agoChange DetectedPublications section was added, featuring the BilT-02 Clin Cancer Res. citation and a 'From PubMed' note indicating automated PubMed population. The revision tag on the page updated from v3.6.3 to v3.6.4.SummaryDifference0.3%

Stay in the know with updates to Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page.